Zoetis Inc. Income Tax Expense
Zoetis Inc. (ZTS) reported Income Tax Expense of $175.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-06
- Zoetis Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $175.00M, a 5.91% decline year-over-year.
- Zoetis Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $157.00M, a 8.19% decline year-over-year.
- Zoetis Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $158.00M, a 4.64% increase year-over-year.
- Zoetis Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $166.00M, a 8.79% decline year-over-year.
- Zoetis Inc. income tax expense (benefit) for fiscal 2025 was $687.00M, a 7.85% increase from fiscal 2024.
- Zoetis Inc. income tax expense (benefit) for fiscal 2024 was $637.00M, a 6.88% increase from fiscal 2023.
- Zoetis Inc. income tax expense (benefit) for fiscal 2023 was $596.00M, a 9.36% increase from fiscal 2022.
- Zoetis Inc. income tax expense (benefit) for fiscal 2022 was $545.00M, a 20.04% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175.00M 10-Q · filed 2026-08-06 | $332.00M 10-Q · filed 2026-08-06 | $490.00M derived: sum of 3 quarters · filed 2026-08-06 | $656.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $157.00M 10-Q · filed 2026-05-07 | $315.00M derived: sum of 2 quarters · filed 2026-05-07 | $481.00M derived: sum of 3 quarters · filed 2026-05-07 | $667.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $158.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $324.00M derived: sum of 2 quarters · filed 2026-02-12 | $510.00M derived: sum of 3 quarters · filed 2026-08-06 | $687.00M 10-K · filed 2026-02-12 | ||
| 2025-09-30 | $166.00M 10-Q · filed 2025-11-04 | $352.00M derived: sum of 2 quarters · filed 2026-08-06 | $529.00M 10-Q · filed 2025-11-04 | $674.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $186.00M 10-Q · filed 2026-08-06 | $184.00M 10-Q · filed 2025-08-05 | $357.00M 10-Q · filed 2026-08-06 | $363.00M 10-Q · filed 2025-08-05 | $508.00M derived: sum of 3 quarters · filed 2026-08-06 | $690.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $171.00M 10-Q · filed 2026-05-07 | $179.00M 10-Q · filed 2025-05-06 | $322.00M derived: sum of 2 quarters · filed 2026-05-07 | $504.00M derived: sum of 3 quarters · filed 2026-05-07 | $660.00M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $151.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $333.00M derived: sum of 2 quarters · filed 2026-02-12 | $489.00M derived: sum of 3 quarters · filed 2026-02-12 | $637.00M 10-K · filed 2026-02-12 | ||
| 2024-09-30 | $182.00M 10-Q · filed 2025-11-04 | $338.00M derived: sum of 2 quarters · filed 2025-11-04 | $486.00M 10-Q · filed 2025-11-04 | $613.00M derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-06-30 | $156.00M 10-Q · filed 2025-08-05 | $304.00M 10-Q · filed 2025-08-05 | $431.00M derived: sum of 3 quarters · filed 2026-02-12 | $552.00M derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-03-31 | $148.00M 10-Q · filed 2025-05-06 | $275.00M derived: sum of 2 quarters · filed 2026-02-12 | $396.00M derived: sum of 3 quarters · filed 2026-02-12 | $598.00M derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2023-12-31 | $127.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $248.00M derived: sum of 2 quarters · filed 2026-02-12 | $450.00M derived: sum of 3 quarters · filed 2026-02-12 | $596.00M 10-K · filed 2026-02-12 | ||
| 2023-09-30 | $121.00M 10-Q · filed 2024-11-04 | $323.00M derived: sum of 2 quarters · filed 2024-11-04 | $469.00M 10-Q · filed 2024-11-04 | $601.00M derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-06-30 | $202.00M 10-Q · filed 2024-08-06 | $348.00M 10-Q · filed 2024-08-06 | $480.00M derived: sum of 3 quarters · filed 2025-02-13 | $619.00M derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-03-31 | $146.00M 10-Q · filed 2024-05-02 | $278.00M derived: sum of 2 quarters · filed 2025-02-13 | $417.00M derived: sum of 3 quarters · filed 2025-02-13 | $558.00M derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2022-12-31 | $132.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $271.00M derived: sum of 2 quarters · filed 2025-02-13 | $412.00M derived: sum of 3 quarters · filed 2025-02-13 | $545.00M 10-K · filed 2025-02-13 | ||
| 2022-09-30 | $139.00M 10-Q · filed 2023-11-02 | $280.00M derived: sum of 2 quarters · filed 2023-11-02 | $413.00M 10-Q · filed 2023-11-02 | $506.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | $141.00M 10-Q · filed 2023-08-08 | $274.00M 10-Q · filed 2023-08-08 | $367.00M derived: sum of 3 quarters · filed 2024-02-13 | $474.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-03-31 | $133.00M 10-Q · filed 2023-05-04 | $226.00M derived: sum of 2 quarters · filed 2024-02-13 | $333.00M derived: sum of 3 quarters · filed 2024-02-13 | $458.00M derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | $93.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $200.00M derived: sum of 2 quarters · filed 2024-02-13 | $325.00M derived: sum of 3 quarters · filed 2024-02-13 | $454.00M 10-K · filed 2024-02-13 | ||
| 2021-09-30 | $107.00M 10-Q · filed 2022-11-03 | $232.00M derived: sum of 2 quarters · filed 2022-11-03 | $361.00M 10-Q · filed 2022-11-03 | $423.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | $125.00M 10-Q · filed 2022-08-04 | $254.00M 10-Q · filed 2022-08-04 | $316.00M derived: sum of 3 quarters · filed 2023-02-14 | $434.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | $129.00M 10-Q · filed 2022-05-05 | $191.00M derived: sum of 2 quarters · filed 2023-02-14 | $309.00M derived: sum of 3 quarters · filed 2023-02-14 | $415.00M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | $62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $180.00M derived: sum of 2 quarters · filed 2023-02-14 | $286.00M derived: sum of 3 quarters · filed 2023-02-14 | $360.00M 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $118.00M 10-Q · filed 2021-11-04 | $224.00M derived: sum of 2 quarters · filed 2021-11-04 | $298.00M 10-Q · filed 2021-11-04 | $351.00M derived: sum of 4 quarters · filed 2021-11-04 | ||
| 2020-06-30 | $106.00M 10-Q · filed 2021-08-05 | $180.00M 10-Q · filed 2021-08-05 | $233.00M derived: sum of 3 quarters · filed 2021-08-05 | $328.00M derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $74.00M 10-Q · filed 2021-05-06 | $127.00M derived: sum of 2 quarters · filed 2021-05-06 | $222.00M derived: sum of 3 quarters · filed 2021-05-06 | $306.00M derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $53.00M 10-K · filed 2020-02-13 | $148.00M derived: sum of 2 quarters · filed 2020-11-05 | $232.00M derived: sum of 3 quarters · filed 2020-11-05 | $301.00M 10-K · filed 2022-02-15 | ||
| 2019-09-30 | $95.00M 10-Q · filed 2020-11-05 | $179.00M derived: sum of 2 quarters · filed 2020-11-05 | $248.00M 10-Q · filed 2020-11-05 | $321.00M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $84.00M 10-Q · filed 2020-08-06 | $153.00M 10-Q · filed 2020-08-06 | $226.00M derived: sum of 3 quarters · filed 2020-08-06 | $297.00M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $69.00M 10-Q · filed 2020-05-06 | $142.00M derived: sum of 2 quarters · filed 2020-05-06 | $213.00M derived: sum of 3 quarters · filed 2020-05-06 | $268.00M derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $73.00M 10-K · filed 2020-02-13 | $144.00M derived: sum of 2 quarters · filed 2020-02-13 | $199.00M derived: sum of 3 quarters · filed 2020-02-13 | $266.00M 10-K · filed 2021-02-16 | ||
| 2018-09-30 | $71.00M 10-K · filed 2020-02-13 | $126.00M derived: sum of 2 quarters · filed 2020-02-13 | $193.00M 10-Q · filed 2019-11-07 | $543.00M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $55.00M 10-K · filed 2020-02-13 | $122.00M 10-Q · filed 2019-08-06 | $472.00M derived: sum of 3 quarters · filed 2020-02-13 | $589.00M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $67.00M 10-K · filed 2020-02-13 | $417.00M derived: sum of 2 quarters · filed 2020-02-13 | $534.00M derived: sum of 3 quarters · filed 2020-02-13 | $632.00M derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-12-31 | $350.00M 10-K · filed 2019-02-14 | $467.00M derived: sum of 2 quarters · filed 2019-02-14 | $565.00M derived: sum of 3 quarters · filed 2019-02-14 | $663.00M 10-K · filed 2020-02-13 | ||
| 2017-10-01 | $117.00M 10-K · filed 2019-02-14 | $215.00M derived: sum of 2 quarters · filed 2019-02-14 | $313.00M 10-Q · filed 2018-11-01 | $390.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-07-02 | $98.00M 10-K · filed 2019-02-14 | $196.00M 10-Q · filed 2018-08-02 | $273.00M derived: sum of 3 quarters · filed 2019-02-14 | $369.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-04-02 | $98.00M 10-K · filed 2019-02-14 | $175.00M derived: sum of 2 quarters · filed 2019-02-14 | $271.00M derived: sum of 3 quarters · filed 2019-02-14 | $379.00M derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2016-12-31 | $77.00M 10-K · filed 2018-02-15 | $173.00M derived: sum of 2 quarters · filed 2018-02-15 | $281.00M derived: sum of 3 quarters · filed 2018-02-15 | $409.00M 10-K · filed 2019-02-14 | ||
| 2016-10-02 | $96.00M 10-K · filed 2018-02-15 | $204.00M derived: sum of 2 quarters · filed 2018-02-15 | $332.00M 10-Q · filed 2017-11-02 | $381.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-07-03 | $108.00M 10-K · filed 2018-02-15 | $236.00M 10-Q · filed 2017-08-08 | $285.00M derived: sum of 3 quarters · filed 2018-02-15 | $368.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-04-03 | $128.00M 10-K · filed 2018-02-15 | $177.00M derived: sum of 2 quarters · filed 2018-02-15 | $260.00M derived: sum of 3 quarters · filed 2018-02-15 | $269.00M derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2015-12-31 | $49.00M 10-K · filed 2017-02-16 | $132.00M derived: sum of 2 quarters · filed 2017-02-16 | $141.00M derived: sum of 3 quarters · filed 2017-02-16 | $206.00M 10-K · filed 2018-02-15 | ||
| 2015-09-27 | $83.00M 10-K · filed 2017-02-16 | $92.00M derived: sum of 2 quarters · filed 2017-02-16 | $157.00M 10-Q · filed 2016-11-03 | $186.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-06-28 | $9.00M 10-K · filed 2017-02-16 | $74.00M 10-Q · filed 2016-08-05 | $103.00M derived: sum of 3 quarters · filed 2017-02-16 | $174.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-03-29 | $65.00M 10-K · filed 2017-02-16 | $94.00M derived: sum of 2 quarters · filed 2017-02-16 | $165.00M derived: sum of 3 quarters · filed 2017-02-16 | $226.00M derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2014-12-31 | $29.00M 10-K · filed 2016-02-24 | $100.00M derived: sum of 2 quarters · filed 2016-02-24 | $161.00M derived: sum of 3 quarters · filed 2016-02-24 | $233.00M 10-K · filed 2017-02-16 | ||
| 2014-09-28 | $71.00M 10-K · filed 2016-02-24 | $132.00M derived: sum of 2 quarters · filed 2016-02-24 | $204.00M 10-Q · filed 2015-11-05 | $226.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-29 | $61.00M 10-K · filed 2016-02-24 | $133.00M 10-Q · filed 2015-08-06 | $155.00M derived: sum of 3 quarters · filed 2016-02-24 | $209.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-30 | $72.00M 10-K · filed 2016-02-24 | $94.00M derived: sum of 2 quarters · filed 2016-02-24 | $148.00M derived: sum of 3 quarters · filed 2016-02-24 | $207.00M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $22.00M 10-K · filed 2015-02-27 | $76.00M derived: sum of 2 quarters · filed 2015-02-27 | $135.00M derived: sum of 3 quarters · filed 2015-02-27 | $187.00M 10-K · filed 2016-02-24 | ||
| 2013-09-29 | $54.00M 10-K · filed 2015-02-27 | $113.00M derived: sum of 2 quarters · filed 2015-02-27 | $165.00M 10-Q · filed 2014-11-10 | $249.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $59.00M 10-K · filed 2015-02-27 | $111.00M 10-Q · filed 2014-08-12 | $195.00M derived: sum of 3 quarters · filed 2015-02-27 | $247.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $52.00M 10-K · filed 2015-02-27 | $136.00M derived: sum of 2 quarters · filed 2015-02-27 | $188.00M derived: sum of 3 quarters · filed 2015-02-27 | $267.00M derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $84.00M 10-K · filed 2014-03-26 | $136.00M derived: sum of 2 quarters · filed 2014-03-26 | $215.00M derived: sum of 3 quarters · filed 2014-03-26 | $274.00M 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $52.00M 10-K · filed 2014-03-26 | $131.00M derived: sum of 2 quarters · filed 2014-03-26 | $190.00M 10-Q · filed 2013-11-13 | |||
| 2012-07-01 | $79.00M 10-K · filed 2014-03-26 | $138.00M 10-Q · filed 2013-08-14 | ||||
| 2012-04-01 | $59.00M 10-K · filed 2014-03-26 | |||||
| 2011-12-31 | $146.00M 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |